What question did this study set out to answer?

The study aims to understand how MYCN activation influences the tumor microenvironment in neuroblastoma and its impact on treatment response.

Distinct Microenvironments Define Neuroblastoma Subtypes and Treatment Response

View Full Paper

Ask AI

Bookmark

Authors

This research characterizes neuroblastoma microenvironments, revealing subtype differences in immune cell presence and treatment implications.

The study aims to understand how MYCN activation influences the tumor microenvironment in neuroblastoma and its impact on treatment response.
Utilized CO-Detection by indEXing (CODEX) for multiplex immunohistochemistry on tissue microarrays.
Employed Visium HD spatial transcriptomics to analyze regional malignant programs and immune infiltrates.
Applied natural language processing to detect spatial cell networks in tumor tissues.
Conducted RNA sequencing to examine immune and cytokine responses in MYCN-amplified cell lines.
Identified a T cell-poor, myeloid-rich microenvironment in MYCN-amplified neuroblastoma.
Found that retinoic acid enhances class I antigen presentation and pro-inflammatory cytokines in MYCN-amplified tumors.
Discovered significant differences in immune cell composition between MYCN-amplified and non-amplified tumors.

Toker et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

This research characterizes neuroblastoma microenvironments, revealing subtype differences in immune cell presence and treatment implications.